Abbott’s Takedown Shakedown – an update
Following action from users, admins, healthcare staff and advocates, Abbott have responded on the takedown shenanigans. This seems to be a company statement that has […]
Following action from users, admins, healthcare staff and advocates, Abbott have responded on the takedown shenanigans. This seems to be a company statement that has […]
Over the past 48 hours, numerous Facebook groups across Europe that were unaffiliated with Abbott but provided “User group” services to Freestyle Libre users received […]
Breaking news in the world of Diabetes tech today saw Medtronic and Abbott share news of a partnership to provide Abbott CGM technology to Medtronic […]
As I mentioned a couple of weeks ago, I received a number of Libre2 and Libre2 Plus devices to try. So far, I’ve only used […]
What impact does a botched rollout of an app update have on a CGM provider?
As I’m currently testing a Libre3, and have taken a look back at the various accuracy studies as a part of this to review MARD data, […]
As a headline, this seems like a harsh statement to make. As an observation of the organisation and effectiveness of England’s healthcare model, perhaps less […]
It was only a little over a week ago that Abbott released their Libre Sense, offering up CGM for athletes without a medical approval, with […]
Whilst that’s a very poor nod to Shakespeare, Libre Sense is the question here. And that’s because they announced the launch of a “Glucose Sport […]
As many of us do going in to the new year, I made a decision to be more active, eat more healthily, etc. The usual […]
Copyright © 2024 | WordPress Theme by MH Themes